• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Can Brain MRI-Based Connectome Mapping Predict the Progression of Parkinson's Disease?

News
Article

For patients with mild Parkinson’s disease, new research suggests that indexes of disease pathology with structural and functional connectivity of brain regions can help predict progression of gray matter atrophy at two- and three-year follow-up brain MRI exams.

Emerging research suggests the use of brain magnetic resonance imaging (MRI) in connectome mapping of structural and functional connectivity may help predict gray matter (GM) atrophy progression in patients with mild Parkinson’s disease (PD).

For the prospective study, recently published in Radiology, researchers utilized diffusion tensor imaging and resting-state functional MRI as a basis for connectome mapping of structural and functional connectivity in the brain. Reviewing data from 86 participants with mild PD (mean age of 60) and 60 healthy control participants (mean age of 62), the study authors evaluated structural and functional disease exposure (DE) indexes of GM regions and performed follow-up 1.5T MRI exams for three years.

In patients with Parkinson’s disease, the study authors found that structural and functional DE indexes at one- and two-year follow-up brain MRI exams correlated with the progression of GM atrophy found with two- and three-year follow-up brain MRI exams.

For patients with mild Parkinson’s disease, new research suggests that indexes of disease pathology with structural and functional connectivity of brain regions can help predict progression of gray matter atrophy at two- and three-year follow-up brain MRI exams.

Here one can see patterns of gray matter atrophy at two-year and three-year follow-up exams for patients with mild Parkinson’s disease (PD). The study authors noted that “ … cortical thinning in frontal, temporal, and parietal regions and the hippocampus and thalamus is associated with conversion to more severe cognitive impairment in PD.” (Images courtesy of Radiology.)

Specifically, the researchers noted that models including DE indexes and GM atrophy changes were prognostic for the progression of GM atrophy in the right caudate nucleus as well as some frontal, temporal, and parietal regions of the brain.

“During the follow-up period, participants with mild PD displayed progressive cortical thinning in the left hemisphere (mainly in the temporal and parietal lobes), with no change in GM volumes. This atrophy reflects the distribution of misfolded α-synuclein and subsequent progressive neuronal loss. … Notably, our GM results highlight left hemispheric lateralization, consistent with literature showing left hemisphere susceptibility in PD and in neurodegenerative diseases in general,” wrote lead study author Silvia Basaia, M.D., who is affiliated with the Neuroimaging Research Unit within the Division of Neuroscience at the IRCCS San Raffaele Scientific Institute in Milan, Italy, and colleagues.

In contrast to prior studies, the study authors noted they were able to evaluate changes to cortical thickness and volume in the brain over a three-year period and noted a clear correlation between DE indexes of structural connectivity and functional connectivity.

“In other words, changes in physical connections between different regions of the brain appear to be related to changes in how these regions functionally communicate,” explained Basaia and colleagues.

Three Key Takeaways

1. Predictive value of MRI-based connectome mapping for gray matter atrophy in Parkinson's disease. Brain MRI, specifically through connectome mapping based off diffusion tensor imaging and resting-state functional MRI, can help predict the progression of gray matter (GM) atrophy in patients with mild Parkinson's disease (PD).

2. Correlation of disease exposure Indexes with GM atrophy. Structural and functional disease exposure (DE) indexes correlate with the progression of GM atrophy over time, particularly in the right caudate nucleus and regions of the frontal, temporal, and parietal lobes.

3. Left hemisphere vulnerability in the brain. The study notes progressive cortical thinning in the left hemisphere of the brain in PD patients, which is consistent with previous literature on the susceptibility of the left hemisphere in neurodegenerative diseases.

In addition to the right caudate nucleus, the researchers noted the prognostic accuracy of GM atrophy progression with some of the temporal, parietal, and frontal brain regions.

“Early temporal lobe atrophy and subsequent frontal and parietal lobe degeneration may serve as biomarkers for the development of multidomain cognitive impairment and progression to PD with mild cognitive impairment. Furthermore, cortical thinning in frontal, temporal, and parietal regions and the hippocampus and thalamus is associated with conversion to more severe cognitive impairment in PD,” emphasized Basaia and colleagues.

While noting that “gray matter atrophy is an indirect measure of neurodegeneration, Kei Yamada, M.D., Ph.D., in an accompanying editorial, said the study authors clearly demonstrated a staged progression with Parkinson’s disease.

“(The researchers) were successful in showing that there is indeed a correlation between the functional and structural organization of the brain and the pattern of cortical atrophy,” wrote Dr. Yamada, who is affiliated with the Department of Radiology at Kyoto Prefectural University of Medicine in Kyoto, Japan.

(Editor’s note: For related content, see “Essential Keys to MRI Safety in the Age of Advanced Diagnostics,” “Video Interview: Is There an Increased Incidence of Neurodegenerative Diseases in Patients with COVID-19?” and “Emerging AI Software for Brain MRI Gets FDA Nod.”)

In regard to study limitations, the authors acknowledged using a 1.5T magnetic field and noted challenges with false-positive rates when employing a false discovery rate to assess changes in gray matter.

Related Videos
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Nina Kottler, MD, MS
Practical Insights on CT and MRI Neuroimaging and Reporting for Stroke Patients
Related Content
© 2024 MJH Life Sciences

All rights reserved.